SeaStar Medical Holding Corp

SeaStar Medical Holding Corp, which traded under the ticker LMAO, originated as LMF Acquisition Opportunities, Inc., a blank-check company that completed its initial public offering in 2021 and targeted the healthcare and medical device sector. The SPAC was sponsored by LMF Capital and filed a Form 10-Q with the SEC on May 24, 2021, under accession number 0001564590-21-029539, reflecting its early operational status as a pre-combination entity. The company ultimately pursued a business combination with SeaStar Medical, a developer of selective cytopheretic device technology aimed at treating inflammatory conditions including acute kidney injury. Sign up for full data, filings, and deal timelines on SpacDesk.